AEON Biopharma, Inc.
AEON- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001837607
In the last 90 days, AEON Biopharma, Inc. insiders filed 1 open-market purchase and 0 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $9.22M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in AEON Biopharma, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +3 vs. Q2 2025
- Shares held
- 1.36M
- +93.2K (+7.3%) vs. Q2 2025
- Total value
- $1.10M
- +$517.6K (+88.4%) vs. Q2 2025
- New holders
- 5
- 2 more added
- Sold out
- 2
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AEON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $9.22M |
| Q1 2026 | 24 | $2.80M |
| Q4 2025 | 22 | $1.67M |
| Q3 2025 | 21 | $1.10M |
| Q2 2025 | 18 | $585.7K |
| Q1 2025 | 16 | $884.8K |
| Q4 2024 | 37 | $4.80M |
| Q3 2024 | 30 | $10.1M |
| Q2 2024 | 25 | $8.73M |
| Q1 2024 | 27 | $103.5M |
| Q4 2023 | 20 | $56.8M |
| Q3 2023 | 16 | $29.3M |
| Q2 2023 | 17 | $12.0M |
| Q1 2023 | 21 | $19.6M |
| Q4 2022 | 86 | $248.3M |
| Q3 2022 | 81 | $226.5M |
| Q2 2022 | 73 | $213.1M |
| Q1 2022 | 71 | $202.3M |
| Q4 2021 | 73 | $192.0M |
| Q3 2021 | 59 | $171.8M |
| Q2 2021 | 47 | $126.0M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding AEON Biopharma, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 1,125,000 | $909.7K | 2.39% | 00.0% | Unchanged |
| Vanguard Group Inc | 98,568 | $79.7K | 0.00% | +98,568 | New |
| Geode Capital Management, LLC | 47,073 | $38.1K | 0.00% | +26,378+127.5% | Added |
| Blue Owl Capital Holdings LP | 42,353 | $34.2K | 0.01% | 00.0% | Unchanged |
| StoneX Group Inc. | 17,578 | $14.2K | 0.00% | +17,578 | New |
| XTX Topco Ltd | 16,162 | $13.1K | 0.00% | +16,162 | New |
| Jane Street Group, LLC | 10,420 | $8.43K | 0.00% | +10,420 | New |
| BlackRock, Inc. | 2,834 | $2.29K | 0.00% | −21−0.7% | Reduced |
| Bank of America Corp | 2,376 | $1.92K | 0.00% | −9−0.4% | Reduced |
| UBS Group AG | 1,192 | $964 | 0.00% | −30,408−96.2% | Reduced |
| DuPont Capital Management Corp | 170 | $137 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 150 | $121 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 106 | $86 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 100 | $81 | 0.00% | 00.0% | Unchanged |
| GHP Investment Advisors, Inc. | 95 | $77 | 0.00% | +71+295.8% | Added |
| Wells Fargo & Company | 90 | $73 | 0.00% | 00.0% | Unchanged |
| Wolff Wiese Magana LLC | 67 | $55 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 58 | $47 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 33 | $27 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 21 | $17 | 0.00% | +21 | New |
| Danske Bank A/S | 1 | $1 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −45,258−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −272−100.0% | Sold out |